Physician profile
Neera Gupta
NPI 1962688507
$833.55
in general payments reported to CMS, 2019-2025
10 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Addiction Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.74 · 2021: $125 · 2022: $411 · 2023: $138 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $144.35 | 2021-2022 | |
| Indivior INC. | $140.80 | 2021-2025 | Sublocade |
| Braeburn INC. | $123.55 | 2025 | Brixadi |
| Otsuka America Pharmaceutical, INC. | $101.18 | 2021-2022 | |
| Lundbeck LLC | $95.07 | 2022-2023 | Abilify Maintena |
| Abbvie INC. | $87.85 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $71.43 | 2022 | |
| Neurocrine Biosciences, INC. | $28.31 | 2023 | Ingrezza |
| Alkermes, INC. | $24.27 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neera Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.